Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Freshworks Inc (Class A) | Sameer K. Gandhi | Director | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 3,050,000 | 0 | - | 0 | Class A Common Stock | |
| Freshworks Inc (Class A) | Sameer K. Gandhi | Director | 20 Feb 2025 | 3,050,000 | 3,050,000 | - | 0 | Class A Common Stock | ||
| Freshworks Inc (Class A) | Sameer K. Gandhi | Director | 20 Feb 2025 | 3,050,000 | 0 | - | - | Class B Common Stock | ||
| Freshworks Inc (Class A) | Sameer K. Gandhi | Director | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 2,000,000 | 0 | - | 0 | Class A Common Stock | |
| Freshworks Inc (Class A) | Sameer K. Gandhi | Director | 20 Feb 2025 | 2,000,000 | 2,000,000 | - | 0 | Class A Common Stock | ||
| Freshworks Inc (Class A) | Sameer K. Gandhi | Director | 20 Feb 2025 | 2,000,000 | 6,250,000 | - | - | Class B Common Stock | ||
| Lucky Strike Entertainment Corp (Class A) | Brett I. Parker | Director, Executive Vice Chairman | Sale of securities on an exchange or to another person at price $ 11.54 per share. | 20 Feb 2025 | 1,747,434 | 498,092 | - | 11.5 | 20,165,388 | Class A Common Stock |
| Ovid Therapeutics Inc | Jeremy M. Levin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,650,000 | 1,650,000 | - | - | Employee Stock Option (Right to Buy) | |
| Perimeter Soln SA | Edward Goldberg | Director, Vice Chairman | 20 Feb 2025 | 1,200,000 | 1,200,000 | - | - | Stock Option (right to buy) | ||
| DraftKings Inc (Class A) | Matthew Kalish | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,156,506 | 4,706,512 | - | 0 | Class A Common Stock | |
| Amplitude Inc (Class A) | Eric Vishria | Director | 20 Feb 2025 | 1,000,000 | 1,000,000 | - | 0 | Class A Common Stock | ||
| Amplitude Inc (Class A) | Eric Vishria | Director | 20 Feb 2025 | 1,000,000 | 1,685,008 | - | - | Class B Common Stock | ||
| Amplitude Inc (Class A) | Eric Vishria | Director | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 1,000,000 | 0 | - | 0 | Class A Common Stock | |
| iHeartMedia Inc (Class A) New | Robert W. Pittman | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 909,085 | 909,085 | - | - | Restricted Stock Units | |
| iHeartMedia Inc (Class A) New | Richard J. Bressler | Director, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 909,085 | 909,085 | - | - | Restricted Stock Units | |
| Palantir | Alexander C. Karp | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 877,500 | 49,573,851 | - | - | Class B Common Stock | |
| Palantir | Alexander C. Karp | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 877,500 | 21,937,500 | - | - | Restricted Stock Units | |
| Perimeter Soln SA | Haitham Khouri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 800,000 | 800,000 | - | - | Stock Option (right to buy) | |
| Biodesix Inc | Hutton Scott | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 775,000 | 775,000 | - | - | Stock Options (Right to buy) | |
| Ford Motor | Henry Ford | Director | Other type of transaction at price $ 9.39 per share. | 20 Feb 2025 | 774,347 | 315,945 (0%) | 0% | 9.4 | 7,271,118 | Class B Stock, $0.01 par value |
| Palantir | Stephen Cohen | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 675,000 | 12,877,734 | - | - | Class B Common Stock | |
| Palantir | Stephen Cohen | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 675,000 | 3,375,000 | - | - | Restricted Stock Units | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 618,250 | 618,250 | - | - | Option to purchase Common Stock | |
| Perimeter Soln SA | Jeffrey Emery | President - Global Fire Safety | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 600,000 | 600,000 | - | - | Stock Option (right to buy) | |
| Shoals Tech Grp Inc (Class A) | Brandon Moss | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 479,303 | 1,073,003 | - | 0 | Class A Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 425,929 | 425,929 | - | - | Stock Options (Right to buy) | |
| Lucky Strike Entertainment Corp (Class A) | Brett I. Parker | Director, Executive Vice Chairman | 20 Feb 2025 | 393,750 | 0 | - | - | Stock option (right to buy) | ||
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 387,500 | 387,500 | - | - | Restricted Stock Units | |
| JPMC | James S. Dimon | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 269.84 per share. | 20 Feb 2025 | 386,544 | 1,052,369 (0%) | 0% | 269.8 | 104,303,989 | Common Stock |
| Avantor Inc | Michael Stubblefield | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 380,886 | 380,886 | - | - | Stock Options (Right to Buy) | |
| iHeartMedia Inc (Class A) New | Robert W. Pittman | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 375,319 | 4,091,393 (6%) | 0% | 0 | Class A Common Stock, par value $0.001 per share | |
| iHeartMedia Inc (Class A) New | Richard J. Bressler | Director, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 375,319 | 3,567,768 (6%) | 0% | 0 | Class A Common Stock, par value $0.001 per share | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 375,000 | 3,750,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 375,000 | 5,876,498 | - | - | Class A Common Stock | |
| Palantir | Shyam Sankar | See Remarks | 20 Feb 2025 | 375,000 | 1,077,786 | - | - | Class A Common Stock | ||
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 375,000 | 1,875,000 | - | - | Employee Stock Option (Right to buy) | |
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 375,000 | 2,935,422 | - | - | Class B Common Stock | |
| Palantir | Shyam Sankar | See Remarks | 20 Feb 2025 | 375,000 | 2,560,422 | - | - | Class B Common Stock | ||
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 375,000 | 1,875,000 | - | - | Restricted Stock Units | |
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 375,000 | 2,935,422 | - | - | Class B Common Stock | |
| DraftKings Inc (Class A) | R. Stanton Dodge | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 360,070 | 913,096 | - | 0 | Class A Common Stock | |
| Perimeter Soln SA | Noriko Yokozuka | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 360,000 | 360,000 | - | - | Stock Option (right to buy) | |
| Palantir | Alexander C. Karp | Director, See Remarks | 20 Feb 2025 | 357,890 | 6,790,148 | - | - | Class A Common Stock | ||
| Palantir | Alexander C. Karp | Director, See Remarks | 20 Feb 2025 | 357,890 | 49,313,461 | - | - | Class B Common Stock | ||
| Supernus Pharma Inc | Jack A. Khattar | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 331,660 | 331,660 | - | - | Employee Stock Option (Right to Buy) | |
| Crinetics Pharma Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 313,000 | 313,000 | - | - | Stock Option (Right to Buy) | |
| Palantir | Stephen Cohen | Director, See Remarks | 20 Feb 2025 | 308,734 | 309,326 | - | - | Class A Common Stock | ||
| Palantir | Stephen Cohen | Director, See Remarks | 20 Feb 2025 | 308,734 | 12,569,000 | - | - | Class B Common Stock | ||
| Palantir | Stephen Cohen | Director, See Remarks | 20 Feb 2025 | 301,847 | 12,202,734 | - | - | Class B Common Stock | ||
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 102.14 per share. | 20 Feb 2025 | 301,847 | 592 | - | 102.1 | 30,831,317 | Class A Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | 20 Feb 2025 | 301,847 | 302,439 | - | - | Class A Common Stock | ||
| Lucid Diagnostics Inc | Dennis M. McGrath | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 300,000 | 1,343,569 | - | 0 | Common stock | |
| Lucid Diagnostics Inc | Lishan Aklog | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 300,000 | 1,466,627 | - | 0 | Common Stock | |
| Lucid Diagnostics Inc | Michael Adam Gordon | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 300,000 | 700,000 | - | 0 | Common stock | |
| Perimeter Soln SA | Kyle Sable | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Oil States Intl Inc | Cindy B. Taylor | Director, President & CEO | 20 Feb 2025 | 297,952 | 2,124,484 (3%) | 0% | 0 | Common Stock | ||
| Health Catalyst Inc | Daniel Burton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 296,000 | 1,424,047 (3%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 290,000 | 290,000 | - | - | Stock Option (Right to Buy) | |
| Uniti Grp Inc | Kenneth A. Gunderman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 279,099 | 3,165,359 (1%) | 0% | 0 | COMMON STOCK | |
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 262,500 | 262,500 | - | - | Employee Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Margaret Alexander | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 262,500 | 262,500 | - | - | Employee Stock Option (Right to Buy) | |
| Coca-Cola | James Robert Quincey | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 259,310 | 601,856 (0%) | 0% | 0 | Common Stock, $.25 Par Value | |
| N-able Inc | John Pagliuca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 256,148 | 1,701,387 | - | 0 | Common Stock, par value $0.001 per share | |
| Biodesix Inc | Gary Pestano | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 244,400 | 244,400 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | O’Kane Kieran | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 235,000 | 235,000 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Robin Harper Cowie | CFO, Secy & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 235,000 | 235,000 | - | - | Stock Options (Right to buy) | |
| CompoSecure Inc (Class A) | Thomas R. Knott | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.57 per share. | 20 Feb 2025 | 233,070 | 879,963 | - | 16.6 | 3,861,970 | Class A Common Stock |
| CompoSecure Inc (Class A) | John D. Cote | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.57 per share. | 20 Feb 2025 | 233,070 | 879,963 | - | 16.6 | 3,861,970 | Class A Common Stock |
| Palantir | David Glazer | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 232,898 | 526,309 | - | 0 | Class A Common Stock | |
| Palantir | Ryan Taylor | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 232,898 | 403,171 | - | 0 | Class A Common Stock | |
| DraftKings Inc (Class A) | Matthew Kalish | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 45.90 per share. | 20 Feb 2025 | 231,269 | 4,475,243 | - | 45.9 | 10,615,247 | Class A Common Stock |
| Lucky Strike Entertainment Corp (Class A) | Brett I. Parker | Director, Executive Vice Chairman | 20 Feb 2025 | 183,128 | 0 | - | - | Stock option (right to buy) | ||
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 183,090 | 634,412 (0%) | 0% | 0 | Class A Common Stock | |
| Vericel Corp | Dominick C. Colangelo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 182,500 | 182,500 | - | - | Stock Option (Right to Buy) | |
| DraftKings Inc (Class A) | Matthew Kalish | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 47.86 per share. | 20 Feb 2025 | 181,698 | 4,177,016 | - | 47.9 | 8,696,066 | Class A Common Stock |
| Health Catalyst Inc | Jason Alger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 181,000 | 267,712 (0%) | 0% | 0 | Common Stock | |
| Trump Media & Tech Grp Corp | Devin G. Nunes | Director, CEO, President, Chairman | 20 Feb 2025 | 179,291 | 1,208,188 | - | 27.8 | 4,991,461 | Common Stock, par value $0.0001 per share | |
| Vertex Inc (Class A) | David DeStefano | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 176,057 | 176,057 | - | - | Restricted Stock Units | |
| Caribou Biosciences Inc | Steven B. Kanner | Chief Scientific Officer | 20 Feb 2025 | 170,000 | 170,000 | - | - | Option to purchase Common Stock | ||
| Caribou Biosciences Inc | Barbara G. McClung | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 170,000 | 170,000 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ruhi Ahmad Khan | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 170,000 | 170,000 | - | - | Option to purchase Common Stock | |
| Shift4 Payments Inc (Class A) | Jared Isaacman | Director, Chairman & CEO, Ten Percent Owner | 20 Feb 2025 | 160,043 | 1,187,961 | - | 0 | Class C Common Stock | ||
| ETHZilla Corp | Blair Jordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 160,000 | 160,000 | - | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.92 per share. | 20 Feb 2025 | 158,664 | 230,992 (0%) | 0% | 103.9 | 16,488,363 | Common Stock |
| Avantor Inc | Michael Stubblefield | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 157,232 | 1,474,465 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 155,280 | 155,280 | - | - | Restricted Stock Unit-9 | |
| Williams Companies | Alan S. Armstrong | Director, President & CEO | 20 Feb 2025 | 152,559 | 152,559 | - | - | Restricted Stock Units | ||
| Ridgepost Capital Inc | Edwin Poston | Director, See remarks | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 20 Feb 2025 | 152,152 | 2,021,450 | - | 13.0 | 1,977,672 | Class A Common Stock |
| Shoals Tech Grp Inc (Class A) | Dominic Bardos | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 149,783 | 390,667 | - | 0 | Class A Common Stock | |
| Palantir | Shyam Sankar | See Remarks | 20 Feb 2025 | 149,773 | 852,559 | - | - | Class A Common Stock | ||
| Palantir | Shyam Sankar | See Remarks | 20 Feb 2025 | 149,773 | 2,785,649 | - | - | Class B Common Stock | ||
| PureCycle Tech Inc | Dustin Olson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 145,317 | 1,182,227 | - | 0 | Common Stock | |
| Health Catalyst Inc | Daniel LeSueur | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 145,000 | 231,044 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 145,000 | 441,816 (1%) | 0% | 0 | Common Stock | |
| N-able Inc | John Pagliuca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 144,086 | 1,445,239 | - | 0 | Common Stock, par value $0.001 per share | |
| N-able Inc | John Pagliuca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 144,086 | 1,445,239 | - | 0 | Common Stock, par value $0.001 per share | |
| Voyager Therapeutics Inc | Robin Swartz | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 142,500 | 142,500 | - | - | Stock Option (Right to Buy) | |
| Sonoco Products Co. | R. Howard Coker | President & CEO | Grant, award, or other acquisition of securities at price $ 48.85 per share. | 20 Feb 2025 | 142,088 | 507,028 (0%) | 0% | 48.9 | 6,940,999 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 140,000 | 376,950 (1%) | 0% | 0 | Common Stock | |
| Caribou Biosciences Inc | Rachel Haurwitz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 136,750 | 295,450 | - | 0 | Common Stock | |
| VICI Properties | Edward Baltazar Pitoniak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 134,436 | 1,268,544 (0%) | 0% | 0 | Common Stock | |
| Orion Engineered Carbons S.A. | Corning F. Painter | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 133,692 | 1,051,338 (1%) | 0% | 0 | Common Shares, no par value | |
| Uniti Grp Inc | Paul Bullington | SVP-CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 133,415 | 831,237 (0%) | 0% | 0 | COMMON STOCK | |
| JPMC | James S. Dimon | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 269.84 per share. | 20 Feb 2025 | 131,711 | 3,832,455 (0%) | 0% | 269.8 | 35,540,541 | Common Stock |
| JPMC | James S. Dimon | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 269.84 per share. | 20 Feb 2025 | 131,711 | 3,700,744 (0%) | 0% | 269.8 | 35,540,541 | Common Stock |
| Shift4 Payments Inc (Class A) | Jared Isaacman | Director, Chairman & CEO, Ten Percent Owner | 20 Feb 2025 | 131,661 | 797,778 | - | 98.9 | 13,019,956 | Class A Common Stock | |
| Shoals Tech Grp Inc (Class A) | Jeffery Tolnar | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 130,719 | 261,926 | - | 0 | Class A Common Stock | |
| N-able Inc | John Pagliuca | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 128,074 | 1,573,313 | - | 0 | Common Stock, par value $0.001 per share | |
| RingCentral Inc (Class A) | Kira Makagon | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 127,648 | 265,397 (0%) | 0% | 0 | Class A Common Stock | |
| Blend Labs Inc (Class A) | Amir Jafari | HEAD OF FINANCE AND ADMIN. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 125,000 | 1,000,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Amir Jafari | HEAD OF FINANCE AND ADMIN. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 125,000 | 934,623 | - | - | Class A Common Stock | |
| Eastman Kodak Co. | James V. Continenza | Director, Executive Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 122,549 | 1,735,283 (4%) | 0% | 0 | Common Stock, par value $.01 | |
| Biodesix Inc | Pestano Gary | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 122,200 | 122,200 | - | - | Restricted Stock Units | |
| Eastman Chemical | Mark J. Costa | Director, CEO & Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 121,458 | 121,458 | - | - | Employee Stock Option (right to buy) | |
| Biodesix Inc | Robin Harper Cowie | CFO, Secy & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 117,500 | 117,500 | - | - | Restricted Stock Units | |
| Biodesix Inc | O’Kane Kieran | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 117,500 | 117,500 | - | - | Restricted Stock Units | |
| DraftKings Inc (Class A) | Matthew Kalish | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 47.10 per share. | 20 Feb 2025 | 116,529 | 4,358,714 | - | 47.1 | 5,488,516 | Class A Common Stock |
| Oil States Intl Inc | Lloyd A. Hajdik | Executive VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 116,387 | 632,268 (1%) | 0% | 0 | Common Stock | |
| Oil States Intl Inc | Philip S. Moses | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 116,387 | 681,921 (1%) | 0% | 0 | Common Stock | |
| N-able Inc | Tim O’Brien | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 115,266 | 635,796 | - | 0 | Common Stock, par value $0.001 per share | |
| iHeartMedia Inc (Class A) New | Michael B. McGuinness | EVP-Finance & Deputy CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 114,679 | 114,679 | - | - | Restricted Stock Units | |
| iHeartMedia Inc (Class A) New | Michael B. McGuinness | EVP-Finance & Deputy CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 114,679 | 512,620 (0%) | 0% | 0 | Class A Common Stock, par value $0.001 per share | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 114,480 | 114,480 | - | - | Restricted Stock Unit-10 | |
| Alkami Tech Inc | William B. Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 114,188 | 468,029 | - | 0 | Common Stock | |
| Coca-Cola | James Robert Quincey | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.07 per share. | 20 Feb 2025 | 113,875 | 487,981 (0%) | 0% | 70.1 | 7,979,221 | Common Stock, $.25 Par Value |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.99 per share. | 20 Feb 2025 | 113,810 | 5,762,688 | - | 4.0 | 454,102 | Class A Common Stock |
| Lucid Diagnostics Inc | Jacque J. Sokolov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 197,460 | - | 0 | Common Stock | |
| Lucid Diagnostics Inc | Stanley N. Lapidus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 214,392 | - | 0 | Common Stock | |
| Lucid Diagnostics Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 197,460 | - | 0 | Common stock | |
| Lucid Diagnostics Inc | James L. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 282,120 | - | 0 | Common Stock | |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 162,725 | - | 0 | Common Stock | |
| Lucid Diagnostics Inc | Debra J. White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 112,800 | - | 0 | Common Stock | |
| Outfront Media Inc | Matthew Siegel | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 111,866 | 184,271 | - | - | Restricted Share Units | |
| Sanfilippo (John B.) & Son Inc | Jasper B. Sanfilippo | Director, COO, President, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 110,430 | 1,239,233 (14%) | 1% | 0 | Class A - Common Stock | |
| Sanfilippo (John B.) & Son Inc | James J. Sanfilippo | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 110,430 | 1,239,233 (14%) | 1% | 0 | Class A - Common Stock | |
| Olin Corp | Kenneth Todd Lane | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 108,617 | 108,617 | - | - | Restricted Stock Units | |
| Avantor Inc | R. Brent Jones | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 103,878 | 103,878 | - | - | Stock Options (Right to Buy) | |
| VICI Properties | Edward Baltazar Pitoniak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 102,993 | 1,310,584 (0%) | 0% | 0 | Common Stock | |
| Therealreal Inc | Gopal Ajay Madan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.90 per share. | 20 Feb 2025 | 102,386 | 1,327,198 (1%) | 0% | 6.9 | 706,013 | Common Stock |
| ClearSign Tech Corp | Colin James Deller | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 100,393 | 221,699 (0%) | 0% | 0 | Common Stock | |
| Perimeter Soln SA | Haitham Khouri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Perimeter Soln SA | Grant Bowman | President, Specialty Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Roivant Sciences Ltd | Eric Venker | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 20 Feb 2025 | 100,000 | 996,869 | - | 3.9 | 385,000 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 100,000 | 10,926,234 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Eric Venker | President & COO | Sale of securities on an exchange or to another person at price $ 10.65 per share. | 20 Feb 2025 | 100,000 | 896,869 | - | 10.7 | 1,065,000 | Common Shares |
| NCR Atleos Corp | Timothy C. Oliver | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 30.28 per share. | 20 Feb 2025 | 99,338 | 320,959 | - | 30.3 | 3,007,955 | Common Stock |
| CoStar | Christian M. Lown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 97,600 | 134,823 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 124.08 per share. | 20 Feb 2025 | 97,527 | 4,689,225 (7%) | 0% | 124.1 | 12,101,150 | Common Stock |
| Health Catalyst Inc | Benjamin Landry | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 97,500 | 169,750 (0%) | 0% | 0 | Common Stock | |
| Palantir | Alexander C. Karp | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 97,500 | 49,671,351 | - | - | Class B Common Stock | |
| Palantir | Alexander C. Karp | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 97,500 | 2,437,500 | - | - | Restricted Stock Units | |
| Payoneer Global Inc | Beatrice Ordonez | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.48 per share. | 20 Feb 2025 | 96,655 | 2,565,054 | - | 10.5 | 1,012,944 | Common Stock |
| JPMC | James S. Dimon | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 269.84 per share. | 20 Feb 2025 | 96,421 | 1,438,913 (0%) | 0% | 269.8 | 26,017,982 | Common Stock |
| Coca-Cola | Manuel Arroyo | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 94,285 | 239,868 (0%) | 0% | 0 | Common Stock, $.25 Par Value | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 92,000 | 92,000 | - | - | Stock Option (Right to Buy) | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 90,100 | 90,100 | - | - | Stock Options (Right to buy) | |
| DuPont de Nemours | Edward D. Breen | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 89,865 | 294,197 (0%) | 0% | 0 | Common Stock | |
| Citigroup | Andrew John Morton | Head of Markets | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.94 per share. | 20 Feb 2025 | 89,444 | 411,174 (0%) | 0% | 83.9 | 7,508,012 | Common Stock |
| Crinetics Pharma Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 89,000 | 346,485 (1%) | 0% | 0 | Common Stock | |
| Frontier Grp Holdings Inc | Howard M. Diamond | EVP, Legal & Corporate Affairs | Sale of securities on an exchange or to another person at price $ 8.77 per share. | 20 Feb 2025 | 87,830 | 175,886 | - | 8.8 | 770,093 | Common Stock |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 87,319 | 87,319 | - | - | Stock Options (Right to buy) | |
| N-able Inc | Michael Adler | EVP, CTPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 87,090 | 528,224 | - | 0 | Common Stock, par value $0.001 per share | |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience Production | 20 Feb 2025 | 86,565 | 86,565 | - | - | Stock Options (Right to Buy) | ||
| Coca-Cola | John Murphy | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 86,436 | 291,944 (0%) | 0% | 0 | Common Stock, $.25 Par Value | |
| Rollins | Jerry E. Gahlhoff | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 85,750 | 359,799 (0%) | 0% | 0 | Common Stock | |
| Organon & Co. | Kevin Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 84,222 | 229,110 | - | 0 | Common Stock | |
| Shift4 Payments Inc (Class A) | David Taylor Lauber | President | Grant, award, or other acquisition of securities at price $ 98.89 per share. | 20 Feb 2025 | 83,527 | 292,415 | - | 98.9 | 8,259,985 | Class A Common Stock |
| JPMC | James S. Dimon | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 269.84 per share. | 20 Feb 2025 | 83,500 | 3,964,166 (0%) | 0% | 269.8 | 22,531,415 | Common Stock |
| Unity Software Inc | Tomer Bar-Zeev | Director | Sale of securities on an exchange or to another person at price $ 25.44 per share. | 20 Feb 2025 | 83,333 | 3,398,146 | - | 25.4 | 2,119,992 | Common Stock |
| N-able Inc | Frank Colletti | EVP, Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 81,967 | 511,670 | - | 0 | Common Stock, par value $0.001 per share | |
| PureCycle Tech Inc | Dustin Olson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 81,325 | 81,325 | - | - | Employee Stock Option (Right to Buy) | |
| Robinhood Markets Inc (Class A) | Daniel M Gallagher | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 79,295 | 90,300 | - | - | Employee Stock Option (right to buy) | |
| Robinhood Markets Inc (Class A) | Daniel M Gallagher | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.24 per share. | 20 Feb 2025 | 79,295 | 785,937 | - | 10.2 | 811,981 | Class A Common Stock |
| LKQ | Justin L. Jude | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 78,750 | 282,788 (0%) | 0% | 0 | Common Stock | |
| Option Care Health Inc - Registered Shares | John Charles Rademacher | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.00 per share. | 20 Feb 2025 | 78,612 | 688,549 (0%) | 0% | 32 | 2,515,584 | Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 77,640 | 77,640 | - | - | Restricted Stock Unit-9 | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 77,640 | 263,528 (0%) | 0% | 0 | Common Stock | |
| Atlassian Corp (Class A) | Brian Duffy | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 77,571 | 77,571 (0%) | 0% | 0 | Class A Common Stock | |
| Cognex Corp | Matthew Moschner | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 76,924 | 76,924 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lumentum Holdings Inc | Alan S. Lowe | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.34 per share. | 20 Feb 2025 | 76,653 | 279,910 (0%) | 0% | 76.3 | 5,851,690 | Common Stock |
| Health Catalyst Inc | Daniel Burton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 75,437 | 1,499,484 (4%) | 0% | 0 | Common Stock | |
| Blend Labs Inc (Class A) | Brian Kneafsey | Head of Revenue | 20 Feb 2025 | 75,000 | 300,000 | - | - | Restricted Stock Units | ||
| Blend Labs Inc (Class A) | Brian Kneafsey | Head of Revenue | 20 Feb 2025 | 75,000 | 851,759 | - | - | Class A Common Stock | ||
| Palantir | Alexander C. Karp | Director, See Remarks | 20 Feb 2025 | 74,675 | 49,238,786 | - | - | Class B Common Stock | ||
| Palantir | Alexander C. Karp | Director, See Remarks | 20 Feb 2025 | 74,675 | 6,506,933 | - | - | Class A Common Stock | ||
| Lam Research | Seshasayee Varadarajan | Senior Vice President | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 20 Feb 2025 | 74,320 | 179,084 (0%) | 0% | 90 | 6,688,800 | Common Stock |
| Lam Research | Seshasayee Varadarajan | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 74,320 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Lam Research | Seshasayee Varadarajan | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.68 per share. | 20 Feb 2025 | 74,320 | 253,404 (0%) | 0% | 17.7 | 1,313,606 | Common Stock |
| Illinois Tool Works | E. Scott Santi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 163.36 per share. | 20 Feb 2025 | 73,453 | 333,676 (0%) | 0% | 163.4 | 11,999,282 | Common Stock |
| Illinois Tool Works | E. Scott Santi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 73,453 | 0 | - | - | Employee Stock Option | |
| Biodesix Inc | Robin Harper Cowie | CFO, Secy & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 73,398 | 73,398 | - | - | Stock Options (Right to buy) | |
| Vericel Corp | Dominick C. Colangelo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 73,000 | 73,000 | - | - | Restricted Stock Unit | |
| Outfront Media Inc | Nicolas Brien | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 72,740 | 72,740 | - | - | Restricted Share Units | |
| CenterPoint Energy | Jason P. Wells | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 72,272 | 417,001 (0%) | 0% | 0 | Common Stock | |
| Western Midstream Partners LP - Unit | Oscar K. Brown | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 72,063 | 72,063 | - | - | 2025 Phantom Units | |
| Williams Companies | Alan S. Armstrong | Director, President & CEO | 20 Feb 2025 | 71,856 | 444,530 (0%) | 0% | 58.4 | 4,199,983 | Common Stock | |
| Voyager Therapeutics Inc | Robin Swartz | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 71,250 | 169,647 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 71,038 | 71,038 | - | - | Option to Purchase Common Stock | |
| Oil States Intl Inc | Taylor E. Brian | Sr. VP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 69,832 | 197,270 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Linda Llewelyn | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 69,000 | 154,819 (0%) | 0% | 0 | Common Stock | |
| Uniti Grp Inc | Daniel L. Heard | EVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 67,267 | 693,779 (0%) | 0% | 0 | COMMON STOCK | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 67,027 | 67,027 | - | - | Restricted Stock Units | |
| Caribou Biosciences Inc | Tina Albertson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 66,137 | 66,137 | - | - | Option to purchase Common Stock | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.92 per share. | 20 Feb 2025 | 65,787 | 589,977 (0%) | 0% | 103.9 | 6,836,585 | Common Stock |
| Tactile Systems Tech Inc | Sheri Louise Dodd | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,669 | 184,390 (0%) | 0% | 0 | Common Stock | |
| ETHZilla Corp | Lawrence J. Steinman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,000 | 67,534 | - | 0 | Common Stock | |
| ETHZilla Corp | Ryan L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,000 | 65,000 | - | 0 | Common Stock | |
| ETHZilla Corp | Jay Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,000 | 65,000 | - | 0 | Common Stock | |
| ETHZilla Corp | Stephen H. Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,000 | 65,000 | - | 0 | Common Stock | |
| Crinetics Pharma Inc | Stephen F. Betz | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharma Inc | Dana Pizzuti | Chief Med and Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 20 Feb 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | ||
| DraftKings Inc (Class A) | R. Stanton Dodge | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 45.90 per share. | 20 Feb 2025 | 64,735 | 848,361 | - | 45.9 | 2,971,337 | Class A Common Stock |
| Sonoco Products Co. | R. Howard Coker | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.85 per share. | 20 Feb 2025 | 64,722 | 462,365 (0%) | 0% | 48.9 | 3,161,670 | Common Stock |
| Outfront Media Inc | Clive Punter | EVP and Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 64,633 | 106,467 | - | - | Restricted Share Units | |
| Palantir | Stephen Cohen | Director, See Remarks | 20 Feb 2025 | 64,419 | 12,504,581 | - | - | Class B Common Stock | ||
| Palantir | Stephen Cohen | Director, See Remarks | 20 Feb 2025 | 64,419 | 65,011 | - | - | Class A Common Stock | ||
| N-able Inc | Tim O’Brien | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 64,183 | 520,530 | - | 0 | Common Stock, par value $0.001 per share | |
| N-able Inc | Tim O’Brien | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 64,183 | 520,530 | - | 0 | Common Stock, par value $0.001 per share | |
| N-able Inc | Kathleen Pai | EVP, Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 64,037 | 529,121 | - | 0 | Common Stock, par value $0.001 per share | |
| Vertex Inc (Class A) | John R. Schwab | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 63,513 | 63,513 | - | - | Restricted Stock Units | |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 28.22 per share. | 20 Feb 2025 | 62,365 | 505,935 (0%) | 0% | 28.2 | 1,760,252 | Class A Common Stock |
| Lumentum Holdings Inc | Alan S. Lowe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 62,345 | 356,563 (0%) | 0% | 0 | Common Stock | |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 28.79 per share. | 20 Feb 2025 | 61,745 | 572,667 (0%) | 0% | 28.8 | 1,777,515 | Class A Common Stock |
| N-able Inc | Peter C. Anastos | EVP, GC, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 61,475 | 395,732 | - | 0 | Common Stock, par value $0.001 per share | |
| Outfront Media Inc | Matthew Siegel | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 61,423 | 258,996 (0%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Matthew Siegel | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 61,423 | 122,848 | - | - | Restricted Share Units | |
| DuPont de Nemours | Edward D. Breen | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 61,237 | 313,185 (0%) | 0% | 0 | Common Stock | |
| DuPont de Nemours | Jon D. Kemp | President, Electronics & Indus | 20 Feb 2025 | 61,237 | 152,084 (0%) | 0% | 0 | Common Stock | ||
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 28.90 per share. | 20 Feb 2025 | 61,195 | 444,740 (0%) | 0% | 28.9 | 1,768,658 | Class A Common Stock |
| VICI Properties | Edward Baltazar Pitoniak | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.48 per share. | 20 Feb 2025 | 60,953 | 1,207,591 (0%) | 0% | 30.5 | 1,857,847 | Common Stock |
| Therealreal Inc | Rati Sahi Levesque | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.90 per share. | 20 Feb 2025 | 60,943 | 2,307,199 (2%) | 0% | 6.9 | 420,239 | Common Stock |
| Freshworks Inc (Class A) | Sameer K. Gandhi | Director | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 60,463 | 526,084 | - | 0 | Class A Common Stock | |
| Blend Labs Inc (Class A) | Amir Jafari | HEAD OF FINANCE AND ADMIN. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.99 per share. | 20 Feb 2025 | 59,835 | 912,288 | - | 4.0 | 238,742 | Class A Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 102.55 per share. | 20 Feb 2025 | 59,727 | 856,740 | - | 102.6 | 6,125,034 | Class A Common Stock |
| ThredUp Inc (Class A) | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 20 Feb 2025 | 59,358 | 0 | - | 2.7 | 160,860 | Class A Common Stock |
| ThredUp Inc (Class A) | Patricia Nakache | Director | 20 Feb 2025 | 59,358 | 59,358 | - | 0 | Class A Common Stock | ||
| ThredUp Inc (Class A) | Patricia Nakache | Director | 20 Feb 2025 | 59,358 | 2,183,634 | - | - | Class B Common Stock | ||
| Benchmark Electronics Inc | Benck Jeff | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 59,228 | 59,228 | - | - | Performance-based Restricted Stock Units | |
| Benchmark Electronics Inc | Benck Jeff | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 59,228 | 485,725 (1%) | 0% | 0 | Common Stock | |
| Outfront Media Inc | Matthew Siegel | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.33 per share. | 20 Feb 2025 | 58,990 | 269,634 (0%) | 0% | 18.3 | 1,081,287 | Common Stock |
| DuPont de Nemours | Lori D. Koch | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 58,788 | 196,798 (0%) | 0% | 0 | Common Stock | |
| DraftKings Inc (Class A) | Matthew Kalish | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 48.99 per share. | 20 Feb 2025 | 58,089 | 4,118,927 | - | 49.0 | 2,845,780 | Class A Common Stock |
| Orion Engineered Carbons S.A. | Corning F. Painter | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.15 per share. | 20 Feb 2025 | 57,894 | 993,444 (1%) | 0% | 15.1 | 877,094 | Common Shares, no par value |
| N-able Inc | Tim O’Brien | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 57,633 | 578,163 | - | 0 | Common Stock, par value $0.001 per share | |
| VICI Properties | David A. Kieske | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 57,550 | 391,143 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 57,240 | 348,432 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 57,240 | 57,240 | - | - | Restricted Stock Unit-10 | |
| Alkami Tech Inc | Douglas A. Linebarger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 57,094 | 248,762 | - | 0 | Common Stock | |
| Reddit Inc (Class A) | Andrew Vollero | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 189.66 per share. | 20 Feb 2025 | 56,198 | 647,417 | - | 189.7 | 10,658,513 | Class A Common Stock |
| VICI Properties | John W.R. Payne | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 55,430 | 447,617 (0%) | 0% | 0 | Common Stock | |
| Mitek Systems Inc | Edward H. West | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.21 per share. | 20 Feb 2025 | 55,000 | 55,000 (0%) | 0% | 9.2 | 506,407 | Common Sock |
| Uniti Grp Inc | Michael Friloux | EVP-CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 54,655 | 597,238 (0%) | 0% | 0 | COMMON STOCK | |
| Outfront Media Inc | Matthew Siegel | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 54,555 | 54,555 | - | - | Restricted Share Units | |
| Shift4 Payments Inc (Class A) | Jared Isaacman | Director, Chairman & CEO, Ten Percent Owner | 20 Feb 2025 | 54,489 | 743,289 | - | 103.7 | 5,650,509 | Class A Common Stock | |
| Centessa Pharma PLC (ADR) | Saurabh Saha | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.92 per share. | 20 Feb 2025 | 54,225 | 331,792 | - | 15.9 | 863,267 | Ordinary Shares |
| Tapestry | Scott A. Roe | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 54,190 | 54,188 | - | - | Stock Option | |
| Tapestry | Scott A. Roe | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.41 per share. | 20 Feb 2025 | 54,190 | 136,627 (0%) | 0% | 35.4 | 1,918,868 | Common Stock |
| Trump Media & Tech Grp Corp | Vladimir Novachki | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.84 per share. | 20 Feb 2025 | 53,814 | 529,763 | - | 27.8 | 1,498,182 | Common Stock, par value $0.0001 per share |
| Aurora Innovation Inc (Class A) | Ossa Fisher | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.94 per share. | 20 Feb 2025 | 53,336 | 1,733,101 | - | 8.9 | 476,824 | Class A Common Stock |
| Advanced Energy Ind Inc | Stephen D. Kelley | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 53,128 | 0 | - | - | Performance Units | |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.59 per share. | 20 Feb 2025 | 52,976 | 781,427 (1%) | 0% | 36.6 | 1,938,392 | Common Stock |
| Vericel Corp | Michael Halpin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
| Coca-Cola | Nikolaos Koumettis | Europe OU President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 52,381 | 271,261 (0%) | 0% | 0 | Common Stock, $.25 Par Value | |
| Essential Properties Realty Trust Inc | Peter M. Mavoides | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 52,117 | 52,117 | - | - | OP Units | |
| Avantor Inc | Claudius Sokenu | EVP, Chief Legal & Compliance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 51,939 | 51,939 | - | - | Stock Options (Right to Buy) | |
| Piedmont Office Realty Trust Inc (Class A) | Christopher Brent Smith | Director, President & Chief Exec. Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 51,908 | 430,999 (0%) | 0% | - | Common Stock | |
| Piedmont Office Realty Trust Inc (Class A) | Christopher Brent Smith | Director, President & Chief Exec. Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 51,908 | 454,400 | - | - | Restricted Stock Units | |
| ClearSign Tech Corp | Brent Hinds | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 51,176 | 131,686 (0%) | 0% | 0 | Common Stock | |
| DraftKings Inc (Class A) | R. Stanton Dodge | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 47.86 per share. | 20 Feb 2025 | 50,860 | 764,883 | - | 47.9 | 2,434,160 | Class A Common Stock |
| Lightwave Logic Inc | Ronald A. Bucchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.80 per share. | 20 Feb 2025 | 50,000 | 155,260 | - | 0.8 | 40,000 | Common Stock |
| Lightwave Logic Inc | Ronald A. Bucchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 50,000 | 1,030,000 | - | - | Employee Stock Option (Right to Buy) | |
| Blend Labs Inc (Class A) | Winnie Ling | HEAD OF LEGAL AND PEOPLE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 50,000 | 378,781 | - | - | Class A Common Stock | |
| Blend Labs Inc (Class A) | Winnie Ling | HEAD OF LEGAL AND PEOPLE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 50,000 | 100,000 | - | - | Restricted Stock Units | |
| Perimeter Soln SA | Kyle Sable | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| SelectQuote Inc | Sarah Taylor Anderson | (See Remarks) | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 20 Feb 2025 | 50,000 | 1,166 | - | 5.4 | 272,000 | Common Stock, par value $0.01 per share |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 49,984 | 165,296 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 49,984 | 0 | - | - | Restricted Stock Unit-6 | |
| ClearSign Tech Corp | Colin James Deller | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.86 per share. | 20 Feb 2025 | 49,846 | 171,853 (0%) | 0% | 0.9 | 42,808 | Common Stock |
| Arista Networks | Marc Taxay | SVP and General Counsel | 20 Feb 2025 | 49,460 | 51,848 (0%) | 0% | 103.9 | 5,139,883 | Common Stock | |
| Uniti Grp Inc | Ronald J. Mudry | SVP-CHIEF REVENUE OFFICER | 20 Feb 2025 | 48,981 | 567,067 (0%) | 0% | 0 | COMMON STOCK | ||
| A10 Networks Inc | Dhrupad Trivedi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 48,713 | 48,711 | - | - | Performance-based Restricted Stock Units | |
| A10 Networks Inc | Dhrupad Trivedi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 48,713 | 777,097 (1%) | 0% | 0 | Common Stock | |
| Unitedhealth Grp | Andrew P. Witty | Director, CEO, UHG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 48,540 | 48,540 | - | - | Non-Qualified Stock Options (right to buy) | |
| Eastman Kodak Co. | James V. Continenza | Director, Executive Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.43 per share. | 20 Feb 2025 | 48,370 | 1,686,913 (3%) | 0% | 7.4 | 359,389 | Common Stock, par value $.01 |
| Illinois Tool Works | E. Scott Santi | Director | Sale of securities on an exchange or to another person at price $ 264.61 per share. | 20 Feb 2025 | 48,195 | 276,392 (0%) | 0% | 264.6 | 12,752,879 | Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 106.34 per share. | 20 Feb 2025 | 47,876 | 6,433,325 | - | 106.3 | 5,091,301 | Class A Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 101.47 per share. | 20 Feb 2025 | 47,871 | 916,467 | - | 101.5 | 4,857,528 | Class A Common Stock |
| Peloton Interactive Inc | Jennifer Cunningham Cotter | Chief Content Officer | 20 Feb 2025 | 47,457 | 287,507 (0%) | 0% | 9.1 | 432,319 | Class A Common Stock | |
| N-able Inc | Frank Colletti | EVP, Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 47,155 | 429,703 | - | 0 | Common Stock, par value $0.001 per share | |
| N-able Inc | Frank Colletti | EVP, Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 47,155 | 429,703 | - | 0 | Common Stock, par value $0.001 per share | |
| VICI Properties | Samantha Sacks Gallagher | General Counsel and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 46,742 | 345,331 (0%) | 0% | 0 | Common Stock | |
| Sanfilippo (John B.) & Son Inc | John E. Sanfilippo | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 46,723 | 46,723 (0%) | 0% | 0 | Class A - Common Stock | |
| Sanfilippo (John B.) & Son Inc | Jasper B. Sanfilippo | Director, COO, President, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 46,723 | 46,723 (0%) | 0% | 0 | Class A - Common Stock | |
| Organon & Co. | Kevin Ali | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.92 per share. | 20 Feb 2025 | 46,575 | 182,535 | - | 14.9 | 694,899 | Common Stock |
| Vericel Corp | Joseph A. Mara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 46,000 | 123,718 (0%) | 0% | 0 | Common Stock | |
| CenterPoint Energy | Monica Karuturi | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 45,840 | 199,230 (0%) | 0% | 0 | Common Stock | |
| Amplitude Inc (Class A) | Eric Vishria | Director | Other type of transaction at price $ 0.00 per share. | 20 Feb 2025 | 45,651 | 321,859 | - | 0 | Class A Common Stock | |
| CarGurus Inc (Class A) | Langley Steinert | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 37.34 per share. | 20 Feb 2025 | 45,130 | 517,050 (0%) | 0% | 37.3 | 1,685,145 | Class A Common Stock |
| Biodesix Inc | Vazquez Christopher | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 45,050 | 45,050 | - | - | Restricted Stock Units | |
| Fiserv | Guy Chiarello | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 45,000 | 16,802 | - | - | Employee Stock Option (right to buy) | |
| Fiserv | Guy Chiarello | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.33 per share. | 20 Feb 2025 | 45,000 | 272,711 (0%) | 0% | 41.3 | 1,859,850 | Common Stock |
| Ovid Therapeutics Inc | Bart Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Ovid Therapeutics Inc | Barbara G. Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Ovid Therapeutics Inc | Karen Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Ovid Therapeutics Inc | Kevin Joseph Fitzgerald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 44,588 | 115,312 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 44,588 | 0 | - | - | Restricted Stock Unit-5 | |
| Outfront Media Inc | Clive Punter | EVP and Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.33 per share. | 20 Feb 2025 | 44,469 | 239,547 (0%) | 0% | 18.3 | 815,117 | Common Stock |
| ON Semiconductor | Thad Trent | Exec VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 44,404 | 403,338 (0%) | 0% | 0 | Common | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 44,240 | 634,360 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 44,240 | 0 | - | - | Restricted Stock Unit-16 | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 44,240 | 44,240 | - | - | Restricted Stock Unit-16 | |
| RingCentral Inc (Class A) | Vaibhav Agarwal | DEPUTY CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 44,008 | 164,374 (0%) | 0% | 0 | Class A Common Stock | |
| Coca-Cola | Nancy Quan | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 44,000 | 267,330 (0%) | 0% | 0 | Common Stock, $.25 Par Value | |
| Ovid Therapeutics Inc | Jeffrey A. Rona | CBFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 43,750 | 71,875 (0%) | 0% | 0 | Common Stock | |
| Ovid Therapeutics Inc | Margaret Alexander | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 43,750 | 78,685 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Chantelle Yvette Breithaupt | Senior Vice President, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 43,668 | 43,668 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Chantelle Yvette Breithaupt | Senior Vice President, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 43,668 | 131,012 | - | - | Restricted Stock Unit-1 | |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 102.47 per share. | 20 Feb 2025 | 43,618 | 6,581,872 | - | 102.5 | 4,469,737 | Class A Common Stock |
| N-able Inc | Michael Adler | EVP, CTPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 43,545 | 484,679 | - | 0 | Common Stock, par value $0.001 per share | |
| WEX Inc | Melissa D. Smith | Director, Chair, CEO, and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 43,054 | 43,054 | - | - | Restricted Stock Units | |
| Pulmonx Corp | Glendon E. French | Director | Sale of securities on an exchange or to another person at price $ 8.14 per share. | 20 Feb 2025 | 43,036 | 1,024,391 | - | 8.1 | 350,313 | Common Stock |
| Crinetics Pharma Inc | Stephen F. Betz | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 43,000 | 114,358 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharma Inc | Dana Pizzuti | Chief Med and Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 43,000 | 74,748 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 20 Feb 2025 | 43,000 | 94,653 (0%) | 0% | 0 | Common Stock | ||
| Avantor Inc | R. Brent Jones | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 42,881 | 69,646 (0%) | 0% | 0 | Common Stock | |
| Sonoco Products Co. | Rodger D. Fuller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 48.85 per share. | 20 Feb 2025 | 42,742 | 187,649 (0%) | 0% | 48.9 | 2,087,947 | Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 100.61 per share. | 20 Feb 2025 | 42,708 | 964,338 | - | 100.6 | 4,296,702 | Class A Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 104.39 per share. | 20 Feb 2025 | 42,431 | 774,494 | - | 104.4 | 4,429,313 | Class A Common Stock |
| DuPont de Nemours | Edward D. Breen | Director, Executive Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.46 per share. | 20 Feb 2025 | 42,249 | 251,948 (0%) | 0% | 82.5 | 3,483,853 | Common Stock |
| Coca-Cola | Manuel Arroyo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.07 per share. | 20 Feb 2025 | 42,112 | 197,756 (0%) | 0% | 70.1 | 2,950,788 | Common Stock, $.25 Par Value |
| N-able Inc | Michael Adler | EVP, CTPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 41,916 | 441,134 | - | 0 | Common Stock, par value $0.001 per share | |
| N-able Inc | Michael Adler | EVP, CTPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 41,916 | 441,134 | - | 0 | Common Stock, par value $0.001 per share | |
| Coca-Cola | Jennifer Kay Mann | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 41,904 | 191,656 (0%) | 0% | 0 | Common Stock, $.25 Par Value | |
| Coca-Cola | Henrique Braun | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 41,904 | 94,370 (0%) | 0% | 0 | Common Stock, $.25 Par Value | |
| RingCentral Inc (Class A) | John Marlow | SVP, CAdO & GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 41,721 | 371,578 (0%) | 0% | 0 | Class A Common Stock | |
| Avantor Inc | Brittany Hankamer | EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 41,551 | 41,551 | - | - | Stock Options (Right to Buy) | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 41,416 | 585,976 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 41,416 | 0 | - | - | Restricted Stock Unit-12 | |
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 41,416 | 41,416 | - | - | Restricted Stock Unit-12 | |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 106.34 per share. | 20 Feb 2025 | 41,301 | 1,512 | - | 106.3 | 4,392,093 | Class A Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 101.36 per share. | 20 Feb 2025 | 41,244 | 6,625,490 | - | 101.4 | 4,180,566 | Class A Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 41,224 | 389,656 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 41,224 | 41,224 | - | - | Restricted Stock Unit-11 | |
| Arista Networks | Jayshree V. Ullal | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 41,224 | 0 | - | - | Restricted Stock Unit-11 | |
| Orion Engineered Carbons S.A. | Corning F. Painter | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.15 per share. | 20 Feb 2025 | 41,130 | 917,646 (1%) | 0% | 15.2 | 623,120 | Common Shares, no par value |
| N-able Inc | Frank Colletti | EVP, Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,984 | 470,687 | - | 0 | Common Stock, par value $0.001 per share | |
| Caribou Biosciences Inc | Andrew L. Guggenhime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Scott Braunstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Nancy C. Whiting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Dara Richardson-Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Hooker Furnishings Corp | Jeremy R. Hoff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,383 | 40,383 | - | - | Restricted Stock Unit (RSU) | |
| Perimeter Soln SA | Kyle Sable | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Applovin Corp (Class A) | Adam Foroughi | Director, CEO & Chairperson, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Feb 2025 | 40,000 | 2,959,492 | - | 0 | Class A Common Stock | |
| Tapestry | Scott A. Roe | CFO and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.56 per share. | 20 Feb 2025 | 39,893 | 82,437 (0%) | 0% | 86.6 | 3,453,138 | Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 99.39 per share. | 20 Feb 2025 | 39,828 | 6,706,068 | - | 99.4 | 3,958,393 | Class A Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 103.53 per share. | 20 Feb 2025 | 39,815 | 816,925 | - | 103.5 | 4,121,848 | Class A Common Stock |
| Outfront Media Inc | Richard H. Sauer | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 39,774 | 65,518 | - | - | Restricted Share Units | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 39,664 | 39,664 | - | - | Stock Options (Right to buy) | |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 100.41 per share. | 20 Feb 2025 | 39,334 | 6,666,734 | - | 100.4 | 3,949,669 | Class A Common Stock |
| Ameris Bancorp | H. Palmer Proctor | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 39,176 | 355,626 (0%) | 0% | 0 | Common Stock | |
| Trump Media & Tech Grp Corp | Scott Glabe | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.84 per share. | 20 Feb 2025 | 39,078 | 297,498 | - | 27.8 | 1,087,932 | Common Stock, par value $0.0001 per share |
| Allegion | John H. Stone | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 38,442 | 38,442 | - | - | Stock Option (Right to Buy) | |
| Dynatrace Inc | Rick M. Mcconnell | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.42 per share. | 20 Feb 2025 | 38,292 | 508,428 (0%) | 0% | 60.4 | 2,313,790 | Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 104.30 per share. | 20 Feb 2025 | 38,243 | 6,512,072 | - | 104.3 | 3,988,642 | Class A Common Stock |
| Gentex Corp | Steve R. Downing | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,725 | 189,623 (0%) | 0% | 0 | Common Stock | |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 102.47 per share. | 20 Feb 2025 | 37,627 | 129,657 | - | 102.5 | 3,855,812 | Class A Common Stock |
| JPMC | Troy L. Rohrbaugh | Co-CEO CIB | Sale of securities on an exchange or to another person at price $ 269.84 per share. | 20 Feb 2025 | 37,500 | 158,381 (0%) | 0% | 269.8 | 10,118,869 | Common Stock |
| Blend Labs Inc (Class A) | Amir Jafari | HEAD OF FINANCE AND ADMIN. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 37,500 | 75,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Amir Jafari | HEAD OF FINANCE AND ADMIN. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 37,500 | 972,123 | - | - | Class A Common Stock | |
| Caribou Biosciences Inc | Steven B. Kanner | Chief Scientific Officer | 20 Feb 2025 | 37,500 | 435,120 | - | 0 | Common Stock | ||
| Caribou Biosciences Inc | Barbara G. McClung | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,500 | 447,066 | - | 0 | Common Stock | |
| Caribou Biosciences Inc | Ruhi Ahmad Khan | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,500 | 70,500 | - | 0 | Common Stock | |
| Westlake Corp | Albert Y. Chao | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,172 | 37,172 | - | - | Employee Option (right to buy) | |
| Westlake Corp | James Y. Chao | Director, Senior Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,172 | 37,172 | - | - | Employee Option (right to buy) | |
| Avantor Inc | R. Brent Jones | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,164 | 106,810 (0%) | 0% | 0 | Common Stock | |
| Payoneer Global Inc | Tsafi Goldman | Chief Legal & Regulatory Ofcr. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.48 per share. | 20 Feb 2025 | 37,142 | 878,939 | - | 10.5 | 389,248 | Common Stock |
| Aqua Metals Inc | Stephen Cotton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,103 | 601,455 (1%) | 0% | 0 | Common Stock | |
| Meritage Homes Corp | Phillippe Lord | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 37,066 | 143,772 (0%) | 0% | 0 | MTH Common Shares | |
| Align Tech | Joseph M. Hogan | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 36,969 | 36,969 | - | - | Market Stock Unit | |
| Coca-Cola | John Murphy | President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.07 per share. | 20 Feb 2025 | 36,529 | 255,415 (0%) | 0% | 70.1 | 2,559,587 | Common Stock, $.25 Par Value |
| Tactile Systems Tech Inc | Elaine M. Birkemeyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 36,248 | 107,876 (0%) | 0% | 0 | Common Stock | |
| Western Midstream Partners LP - Unit | Oscar K. Brown | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 36,032 | 36,032 | - | - | 2025 Performance Unit-TUR | |
| Western Midstream Partners LP - Unit | Oscar K. Brown | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 36,032 | 36,032 | - | - | 2025 Performance Unit-ROA | |
| Williams Companies | Micheal G. Dunn | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 58.45 per share. | 20 Feb 2025 | 35,928 | 776,114 (0%) | 0% | 58.5 | 2,099,992 | Common Stock |
| VICI Properties | David A. Kieske | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 35,848 | 400,261 (0%) | 0% | 0 | Common Stock | |
| Lam Research | Seshasayee Varadarajan | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.01 per share. | 20 Feb 2025 | 35,760 | 214,844 (0%) | 0% | 19.0 | 679,690 | Common Stock |
| Lam Research | Seshasayee Varadarajan | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 35,760 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Lam Research | Seshasayee Varadarajan | Senior Vice President | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 20 Feb 2025 | 35,760 | 179,084 (0%) | 0% | 90 | 3,218,400 | Common Stock |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience Production | 20 Feb 2025 | 35,734 | 76,924 (0%) | 0% | 0 | Common Stock | ||
| Tapestry | Scott A. Roe | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 35,687 | 107,059 | - | - | Stock Option | |
| Tapestry | Scott A. Roe | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.81 per share. | 20 Feb 2025 | 35,687 | 172,314 (0%) | 0% | 33.8 | 1,206,577 | Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 101.36 per share. | 20 Feb 2025 | 35,579 | 167,284 | - | 101.4 | 3,606,351 | Class A Common Stock |
| Shenandoah Telecom Co. | Christopher E. French | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 35,541 | 393,717 (0%) | 0% | - | Common Stock | |
| Outfront Media Inc | Clive Punter | EVP and Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 35,489 | 70,978 | - | - | Restricted Share Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.